Please watch this space for public announcements related to Applied Protein Sciences.
Apr 29, 2009: First pre-IND meeting between APS and FDA scheduled.
Apr 28, 2009: APS and Biomodels Collaborate to Boost Supportive Cancer Care.
View press release on the websites below, or view them all on the Scribd window on the right:
Feb 20, 2009: APS in-licenses 3 patents to expand its pipeline to include pain relief for supportive oncology.
Feb 15, 2009: APS releases a proposed "Mechanism of Action for AP002".
Jan 22, 2009: Maynard Lichty joins the APS team as Consultant for Product Development.
Dec 13, 2008: Shelley Ching joins the APS team as Consultant for Non-Clinical Development.
Nov 23, 2008: Marna Doucette joins APS team as Consultant for Regulatory Affairs.
Oct 7, 2008: APS launches a comprehensive pre-clinical program for AP002.
Sept 15, 2008: APS announces AP002 pre-clinical results. APS releases pre-clinical test results for its proprietary compound AP002 showing a dramatic activity in mucosal cell proliferation.
June 24, 2008: APS presented at the New York Venture Summit, New York.
June 3, 2008: APS invited to present at the Life Sciences Festival, Sacramento.
Apr 29, 2008: APS patents in the news.
Feb 12, 2008: APS awarded another US patent, US7329645, related to its mucositis platform.